Retatrutide
Triple agonist (GIP/GLP-1/Glucagon) reference material for metabolic pathway research.
Research chemical · Not for human use
Research description
Retatrutide is a novel triple agonist targeting GIP, GLP-1, and glucagon receptors. Supplied as a lyophilized laboratory reference material for in vitro multi-receptor metabolic pathway research. Each vial includes a batch-specific third-party COA.
Intended solely as a laboratory reference material. No claims are made regarding safety, efficacy, or suitability for any clinical, therapeutic, or personal use.
Research Applications
- Triple receptor agonist binding studies
- Energy balance and thermogenesis models
- Multi-pathway metabolic research
- Comparative GLP-1 / GIP / glucagon assays
Reviews
Clean COA, fast ship
20 mg lot matched our HPLC within tolerance. Packaging was cold-chain intact.
Lab Manager, Midwest
Storage
- Lyophilized
- -20°C, protect from light
- Reconstituted
- 2–8°C, up to 14 days for lab use
Laboratory reconstitution
- Recommended diluent
- Bacteriostatic water
- Typical lab concentration
- 1–2 mg/mL for in vitro assays
Guidance for in vitro laboratory preparation only — not dosing or administration instructions.
Related research materials
Semax
RUO · Lab research only
ACTH(4-10) analog for neuroprotective and BDNF pathway research.
Selank
RUO · Lab research only
Tuftsin analog for anxiolytic pathway and GABA modulation research.
Tesamorelin
RUO · Lab research only
Stabilized GHRH analog for sustained GH-axis research.
GLOW
RUO · Lab research only
GHK-Cu + BPC-157 + TB-500 research blend for multi-pathway tissue assays.
$165.00
20 mg